1. Home
  2. BHM vs INCR Comparison

BHM vs INCR Comparison

Compare BHM & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bluerock Homes Trust Inc.

BHM

Bluerock Homes Trust Inc.

HOLD

Current Price

$9.10

Market Cap

40.1M

Sector

Real Estate

ML Signal

HOLD

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$1.04

Market Cap

47.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHM
INCR
Founded
2022
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
40.1M
47.4M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
BHM
INCR
Price
$9.10
$1.04
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
6.4K
66.3K
Earning Date
01-01-0001
05-01-2026
Dividend Yield
4.54%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$68,734,000.00
N/A
Revenue This Year
N/A
$69.54
Revenue Next Year
N/A
$41.75
P/E Ratio
N/A
N/A
Revenue Growth
36.88
N/A
52 Week Low
$8.05
$0.68
52 Week High
$14.81
$1.77

Technical Indicators

Market Signals
Indicator
BHM
INCR
Relative Strength Index (RSI) 38.98 56.76
Support Level $8.77 $0.84
Resistance Level $9.67 $1.23
Average True Range (ATR) 0.49 0.07
MACD -0.03 0.00
Stochastic Oscillator 8.24 61.30

Price Performance

Historical Comparison
BHM
INCR

About BHM Bluerock Homes Trust Inc.

Bluerock Homes Trust Inc owns and operates a portfolio of institutional residential properties including single-family homes, build-to-rent communities, and other residential communities located in attractive markets with a focus on the knowledge-economy and high-quality of life growth markets of the Sunbelt and Western United States. The company's principal objective is to generate attractive risk-adjusted returns on investments where it believes it can drive growth in funds from operations and net asset value by acquiring residential units, developing residential communities, and through value-add renovations. The company has two reportable segments, consisting of Residential Communities, which derives maximum revenue; and Scattered Single-family homes.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: